rs557878787
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020433.5(JPH2):c.1213G>T(p.Ala405Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,612,324 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020433.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249976Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135250
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460090Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726460
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74382
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
A likely pathogenic variant has been identified in the JPH2 gene. The A405S variant has been reported previously as a de novo variant in a 16-year-old male with HCM without atrial arrhythmias (Beavers et al., 2013). The A405S variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The A405S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, this variant is likely pathogenic. -
- -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 405 of the JPH2 protein (p.Ala405Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 23973696, 31227780; internal data). ClinVar contains an entry for this variant (Variation ID: 372724). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects JPH2 function (PMID: 28393127). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.A405S variant (also known as c.1213G>T), located in coding exon 3 of the JPH2 gene, results from a G to T substitution at nucleotide position 1213. The alanine at codon 405 is replaced by serine, an amino acid with similar properties. This variant was reported in an individual from a hypertrophic cardiomyopathy cohort (Beavers DL et al. J. Am. Coll. Cardiol., 2013 Nov;62:2010-9; Quick AP et al. JACC Basic Transl Sci, 2017 Feb;2:56-67). Studies in a mouse model showed that this variant behaved similar to wild type in terms of no increased susceptibility to atrial fibrillation, no increased incidence of spontaneous calcium waves following pacing train, and no disruption to JPH2-RyR2 binding, but mice with this variant did demonstrate subvalvular septal hypertrophy using a novel imaging plane on echocardiogram (Beavers DL et al. J. Am. Coll. Cardiol., 2013 Nov;62:2010-9; Quick AP et al. JACC Basic Transl Sci, 2017 Feb;2:56-67). Additional functional studies demonstrated no increase in amyloid-like aggregates in transfected cells with A405S (Guo A et al. Biochem Biophys Res Commun, 2021 07;563:79-84). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on available evidence to date, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at